| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,543,901 | 1,519,052 | 1,563,560 | 1,598,087 | | Cost of Revenue | 1,177,701 | 1,156,325 | 1,166,138 | 1,182,230 | | | Gross Profit | 366,200 | 362,727 | 397,422 | 415,857 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 202,093 | 197,300 | 225,174 | 236,038 | | Non Recurring | 80,059 | 33,782 | 50,312 | 59,935 | | Others | (27,198) | 21,355 | 26,626 | 28,732 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 132,029 | 110,290 | 95,310 | 91,152 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,202 | 1,032 | 2,407 | 3,771 | | Earnings Before Interest And Taxes | 112,448 | 111,322 | 97,717 | 94,923 | | Interest Expense | 15,864 | 36,697 | 38,089 | 34,146 | | Income Before Tax | 96,584 | 74,625 | 59,628 | 60,777 | | Income Tax Expense | 17,838 | 31,297 | 28,734 | 29,123 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 78,746 | 43,328 | 30,894 | 31,654 | | | Non-recurring Events | | Discontinued Operations | (6,231) | (14,609) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 72,515 | 28,719 | 30,894 | 31,654 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $72,515 | $28,719 | $30,894 | $31,654 |
|
0.29% Nasdaq 
Income Statement
